Angiologia

Idraparinux versus Standard Therapy for Venous Thromboembolic Disease

The long-acting factor X inhibitor idraparinux was compared with a standard antithrombotic regimen in two randomized trials, one for the treatment of deep venous thrombosis (DVT Study) and the other for the treatment of pulmonary embolism (PE Study).
Approfondisci

 http://content.nejm.org/cgi/content/short/357/11/1094?rss=1&...

New England Journal of Medicine